Skip to content

Clinical trials

Endocrine System Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Country / region: Poland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20162
20172
20181
20202
20211
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascendis Pharma Endocrinology Division A/S3
AstraZeneca2
Eli Lilly and Company2
Pfizer2
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma A/S1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sumitomo Pharma America, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases14
Diabetes Mellitus, Type 27
Diabetes Mellitus6
Glucose Metabolism Disorders6
Metabolic Diseases6
Dwarfism, Pituitary4
Body Weight3
Failure to Thrive3
Nutritional and Metabolic Diseases3
Adenocarcinoma2

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.